Skip to content

Clinical trials

Observational Carcinoma, Ovarian Epithelial trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Ovarian Epithelial Phase: Observational Country / region: China Clear all

17 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20172
20182
20193
20202
20211
20222
20234
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status13
Completed3
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Lei Li10
RenJi Hospital3
Anhui Provincial Hospital1
Chongqing University Cancer Hospital1
Hebei Medical University Fourth Hospital1
Peking Union Medical College Hospital1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Ovarian Epithelial17
Disease2
Ovarian Neoplasms2
Carcinogenesis1
Chromosomal Instability1
Hereditary Breast and Ovarian Cancer Syndrome1
Microsatellite Instability1

Trials

Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.